PCN135 - DOES PATIENT SELECTION CRITERIA TRANSLATE INTO COST SAVINGS IN PATIENTS WITH ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER CHEMOTHERAPY FAILURE IN SPAIN?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.218
https://www.valueinhealthjournal.com/article/S1098-3015(18)33518-6/fulltext
Title :
PCN135 - DOES PATIENT SELECTION CRITERIA TRANSLATE INTO COST SAVINGS IN PATIENTS WITH ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER CHEMOTHERAPY FAILURE IN SPAIN?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33518-6&doi=10.1016/j.jval.2018.09.218
First page :
Section Title :
Open access? :
No
Section Order :
1555